ANTCF (Aion Therapeutic) EV-to-Revenue : 3.59 (As of May. 13, 2025)

Aion Therapeutic EV-to-Revenue Chart

Aion Therapeutic Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
EV-to-Revenue	Get a 7-Day Free Trial															35.40	27.92	8.77	8.49	5.27

Competitive Comparison of Aion Therapeutic's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Aion Therapeutic's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aion Therapeutic's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aion Therapeutic's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aion Therapeutic's EV-to-Revenue falls into.

Aion Therapeutic EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Aion Therapeutic's EV-to-Revenue for today is calculated as:

Aion Therapeutic's current Enterprise Value is $3.79 Mil.
Aion Therapeutic's Revenue for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aion Therapeutic  (OTCPK:ANTCF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Aion Therapeutic's PS Ratiofor today is calculated as:

Aion Therapeutic's share price for today is $0.004.
Aion Therapeutic's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aion Therapeutic EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Aion Therapeutic Business Description